| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/01/2007 | US20070027116 Therapeutic phosphonate derivatives |
| 02/01/2007 | US20070027114 cancer and/or viral infection, leukemia; improved pharmacological properties; oral bioavailability, greater potency, extended half-life in vivo, Side effects reduction; 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-6-diethoxy-phosphoryl)-hexanoic acid, diethyl cyano phosphonate |
| 02/01/2007 | US20070027113 Purine nucleoside phosphorylase inhibitory phosphonate compounds |
| 02/01/2007 | US20070027105 Peroxide removal from drug delivery vehicle |
| 02/01/2007 | US20070027090 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 02/01/2007 | US20070027083 Human growth hormone aqueous formulation |
| 02/01/2007 | US20070027075 Compositions and methods for targeted drug delivery |
| 02/01/2007 | US20070026515 Cell or drug encapsulation device having a wet seal |
| 02/01/2007 | US20070026087 Anti-coronavirus agent |
| 02/01/2007 | US20070026066 Oral pharmaceutical delivery system with improved sustained release |
| 02/01/2007 | US20070026050 Mortierella schmuckeri microorganisms are cultured in fermentation medium; a polyunsaturated fatty acid for use in e.g. infant formulas |
| 02/01/2007 | US20070026049 Method of increasing lean body mass and reducing body fat mass in infants |
| 02/01/2007 | US20070026044 Use of VEGF For Treating Bone Defects |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |
| 02/01/2007 | US20070025966 With a sugar or polyethylene glycol; improved antiviral and immunomodulatory efficacy; HIV and hepatitis C vaccines |
| 02/01/2007 | US20070025965 Therapies for renal failure using interferon-beta |
| 02/01/2007 | US20070025952 Linear cyclodextrin copolymers |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | DE112005000612T5 Zusammensetzung zur Stabilisierung von Epigallocatechingallat (EGCG) in Wasserphase und Herstellungsverfahren davon Stabilization composition of epigallocatechin gallate (EGCG) in water phase and manufacturing method thereof |
| 02/01/2007 | CA2617051A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 02/01/2007 | CA2617040A1 Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
| 02/01/2007 | CA2616877A1 Systems and methods for manufacturing liposomes |
| 02/01/2007 | CA2616790A1 Aqueous solution preparation containing camptothecin compounds |
| 02/01/2007 | CA2616788A1 Oral preparation useful in measuring capacity to metabolize pyridine |
| 02/01/2007 | CA2616508A1 Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 02/01/2007 | CA2616443A1 Uses of sporopollenin as an antioxidant |
| 02/01/2007 | CA2616314A1 Antiviral phosphonate conjugates for inhibition of hiv |
| 01/31/2007 | EP1747781A1 Stable oral pharmaceutical preparation comprising fosfomycin, which is intended for diabetic patients |
| 01/31/2007 | EP1747277A1 Method for gene delivery to neuronal cells |
| 01/31/2007 | EP1747262A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 01/31/2007 | EP1747233A1 Compounds for specific viral target |
| 01/31/2007 | EP1747021A2 Self-immolative linkers and drug conjugates |
| 01/31/2007 | EP1747020A2 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists |
| 01/31/2007 | EP1747019A2 Camptothecin derivatives conjugated in position 20 with integrin antagonists |
| 01/31/2007 | EP1747018A2 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
| 01/31/2007 | EP1747017A2 Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
| 01/31/2007 | EP1747003A1 Phospholipase inhibitors localized in the gastrointestinal lumen |
| 01/31/2007 | EP1746984A2 Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity |
| 01/31/2007 | EP1746884A2 Stabilized hyaluronan preparations and related methods |
| 01/31/2007 | EP1536838B1 Hyposensibilisation by hydroxyalkyl starch allergen conjugates |
| 01/31/2007 | EP1365749B1 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 01/31/2007 | EP1303541A4 Gel compositions containing metronidazole |
| 01/31/2007 | EP1194138B1 Nutritional supplements |
| 01/31/2007 | CN1905903A Ghrelin-carrier conjugates |
| 01/31/2007 | CN1905896A Methods of enhancing immune response in the intradermal compartment and compounds useful thereof |
| 01/31/2007 | CN1905889A A medical solution, a method for producing said medical solution and use thereof |
| 01/31/2007 | CN1905887A Myocardial persufion imaging using adenosine receptor agonists |
| 01/31/2007 | CN1905866A Tulobuterol adhesive patch |
| 01/31/2007 | CN1904158A Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application |
| 01/31/2007 | CN1903909A Biodegradable polyester containing phosphatidylcholine group and its preparation method |
| 01/31/2007 | CN1903867A New crystalline type 3,4',5-trihydroxy stilbene-3-beta-D-glucocide |
| 01/31/2007 | CN1903373A Application of expression TRAIL protein colon bacillus for preparing medicine to treat tumor |
| 01/31/2007 | CN1903369A Composition for coating comprising low-substituted cellulose ether for taste-masking and coated preparation therof |
| 01/31/2007 | CN1903368A Targeted, control-release and thin film coating material made of denatured starch for oral medicine to treat colonic diseases, its prepn. and use |
| 01/31/2007 | CN1903367A Chitin medicine carrier, prepn. method and application thereof |
| 01/31/2007 | CN1903366A Targeted nanometer medicine carrier and its prepn. method |
| 01/31/2007 | CN1903365A Drug-carried nanometer particles, and its preparing process for preparing medicien prepn. for anti-restenosis of blood-vessel |
| 01/31/2007 | CN1903358A Compound bone peptide medicine composition oral prepn. and prepn. method therefor |
| 01/31/2007 | CN1903238A Extractive of traditional Chinese medicine, its prepns., preparing method and application thereof |
| 01/31/2007 | CN1903202A Compounding medicine for treating nephropathy |
| 01/31/2007 | CN1903200A Medicine for treating gap and vomiting due to nuclear-radiation, radiotherapy and anti-motion sickness |
| 01/31/2007 | CN1903185A Dispersion tablets and its prepn. method |
| 01/31/2007 | CN1903183A Dispersion tablets of telbivudine and its prepn. method |
| 01/31/2007 | CN1903182A Miniaturization sarpogrelate hydrochloride oral drug-giving preparation |
| 01/31/2007 | CN1903181A Enteric quick-dissolving tablets contg. aconitine, and its prepn. method |
| 01/31/2007 | CN1903180A Freeze-dried powder injection of frusemide and its prepn. method |
| 01/31/2007 | CN1903179A Preparing method of powder agglomerates |
| 01/31/2007 | CN1903178A Powder injection of cinepazet maleate and its prepn. method |
| 01/31/2007 | CN1903177A Alprostadil nano-particles and its prepn. method |
| 01/31/2007 | CN1903176A Dry suspensoid of Repirinast and its prepn. method |
| 01/31/2007 | CN1903175A Skin mucous membrane permeation-promoting solution WBNb with carrier for various kinds of medicines |
| 01/31/2007 | CN1903174A Clotrimazole gel, and its prepn. method |
| 01/31/2007 | CN1903173A Nimodipine nanometer granule and its prepn. method |
| 01/31/2007 | CN1903172A Poloxamer thymic peptide alpha 1 long-acting temp.-sensing gel |
| 01/31/2007 | CN1903171A Nanometer silver type external use antibiotic gel for female external use and its prepn. method |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/31/2007 | CN1297527C Stabilized compositions of aqueous reduced coenzyme Q solution |
| 01/31/2007 | CN1297319C Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium |
| 01/31/2007 | CN1297318C Prepn of core-shell type nano compound hydroxyapatiti-liposome particle |
| 01/31/2007 | CN1297276C 5-amino-salicylic acid intercalation medicinal slow-release agent and production thereof |
| 01/31/2007 | CN1297274C Medical composition |
| 01/31/2007 | CN1297270C Ophthalmic composition comprising ascomycin |
| 01/31/2007 | CN1297253C Medicinal transferring system for intracephalic transference of medicine |
| 01/31/2007 | CN1297252C Concentrated solution of non-foaming ammonium compounds and method of use |
| 01/30/2007 | US7170520 Display for sharing display data channel |
| 01/30/2007 | US7169900 Polyoxyalkylene glycols with amino acid end groups bonded by the amine to hemoglobin by an amide linkage ( Glu-43, Glu-22 and/or Asp-47); blood substitute with increased circulation half-life; low vasoactivity; traps nitric oxide in septic shocks; modulate tissue oxygenation during radiation therapy |
| 01/30/2007 | US7169896 Producing partially modified and partially hydrolysed fiberous protein; isolate feather, solubilize, incubate with reducing agent, recover protein; isolating fiberous protein from waste feathers for use in textile processing and supplementing cosmetics |
| 01/30/2007 | US7169889 Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
| 01/30/2007 | US7169819 A pharmaceutical formulation for parenteral delivery, comprising a retinide such as fenretinide in combination with a solvent (an alcohol) and a alkoxylate castor oil, capable of dispersing or dissolving the retinide; anticancer agent |
| 01/30/2007 | US7169814 Guanidinium transport reagents and conjugates |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169767 Ophthalmic compositions containing galactomannan polymers and borate |
| 01/30/2007 | US7169755 Viscosity-enhancing agent to increase the residence time of the solution in the heating chamber thereby increasing the expulsion force of the solution from the handpiece |
| 01/30/2007 | US7169754 Blood disorders; drug in aqueous solution |
| 01/30/2007 | US7169611 Programmable genotoxic agents and uses therefor |
| 01/30/2007 | US7169434 Drying; extrusion; reducing power needed |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169411 Composition for delivery of biological agents and methods for the preparation thereof |
| 01/30/2007 | US7169406 Drug delivery; analgesics, antiinflammatory agents; contacting skin with hydrogel containing drugs |
| 01/30/2007 | US7169405 chemonucleolysis agent in solid form such that, when the device is placed into the nucleus pulposus of the intervertebral disc, it releases the chemonucleoylysis agent into the nuclear disc tissue surrounding the device to proteolytically degrade the tissue |